• Info
  • Significant Ownership

Significant Ownership of BML Investment Partners, L.P.

Signature - Title
Braden M Leonard - Braden M Leonard - Managing Member of BML Capital Management, LLC
Location
Zionsville, IN
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BML Investment Partners, L.P..

Notify me when BML Investment Partners, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BML Investment Partners, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 13.3% $21.8M 14.3M BML Investment Partners, L.P. Dec 31, 2024
ACHL Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share 9.97% $6.07M 4.1M BML Investment Partners, L.P. Dec 31, 2024
EPIX ESSA Pharma Inc. Common Shares 9.5% $7.6M $69K 4.22M +0.92% BML Investment Partners, L.P. Apr 24, 2025
AVIR Atea Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.5% $21.3M 7.22M Leonard Braden Michael Dec 13, 2024
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 8.5% $4.34M $471K 4.09M +12.2% Leonard Braden Michael Jun 16, 2025
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 8.2% $19.2M 3.72M BML Investment Partners, L.P. Feb 11, 2025
ATHA Athira Pharma Inc. Common Stock, $0.0001 par value 7.8% $848K 3.03M Leonard Braden Michael Dec 31, 2024
LVTX LAVA Therapeutics N.V. Common shares, par value $0.14 per share 7.4% $2.7M 1.96M BML Investment Partners, L.P. Feb 26, 2025
PMVP PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share 6.7% $3.74M 3.47M BML Investment Partners, L.P. Dec 31, 2024
TIL Instil Bio, Inc. Common Stock, $0.000001 par value per share 6.7% $136K 440K Leonard Braden Michael Dec 31, 2024
ORMP ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share 6.55% $5.82M 2.64M BML Investment Partners, L.P. Dec 31, 2024
KZR Kezar Life Sciences, Inc. Common Stock, $0.001 par value 5.1% $284K 369K BML Investment Partners, L.P. Feb 28, 2025
WHWK Aadi Bioscience, Inc. Common stock, par value $0.0001 per share 4.98% $3.75M -$331K 2.44M 0% Leonard Braden Michael Mar 5, 2025
Ikena Oncology, Inc. Common Stock, par value $0.001 per share 1.9% 221K Leonard Braden Michael Jul 25, 2025
ANTX AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share 1.4% $551K -$3.6M 427K -86.7% BML Investment Partners, L.P. Jun 17, 2025
ASTC Astrotech Corporation Common Stock, $0.001 par value per share 0% $0 0 BML Investment Partners, L.P. Oct 3, 2025
CLYM Climb Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BML Investment Partners, L.P. Dec 31, 2024
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 0% $0 0 BML Investment Partners, L.P. Dec 31, 2024
ELEV Elevation Oncology, Inc. Common stock, par value $0.0001 per share 0% $0 -$2.16M 0 -100% BML Investment Partners, L.P. Jul 23, 2025
ADVM Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share 0% -$9.74M 0 -100% BML Investment Partners, L.P. Dec 9, 2025

Schedules 13D/G Reported by BML Investment Partners, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.